DUBLIN–(BUSINESS WIRE)–The “2023 Microbiome Market Trend” report has been added to ResearchAndMarkets.com’s offering.
The microbiome therapeutics market is successfully commercializing Seres Therapeutics’ SER-109 and Rebiotix’s RBX-2660 for recurrent Clostridium difficile infection (Recurrent C. difficile).
While integrated omics-based projects are underway, researchers focus more on differences in gut microbiota between individuals that may be associated with disease expression. Still, they have yet to identify concrete biomarkers. While integrated omics analysis relies on correlation coefficients and algorithms, researchers are employing several omics approaches, and research is shifting from specific strains to multi-strain consortia.
This report covers the efforts of companies involved in the microbiome market. Also, it covers a wide range of topics, including market size, technology trends, applications in sequencing, health food, agriculture, livestock, skincare, industrial processes, regulations, and marketing. Trends in the global microbiome market are also summarized by country (and some areas), and the current market size, competitive landscape, and challenges are analyzed and forecasted for the future.
Countries Covered
- United States
- Canada
- Germany
- France
- United Kingdom
- China
- Japan
- India
- Others
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 69 |
| Forecast Period | 2022 – 2027 |
| Estimated Market Value (USD) in 2022 | $71.55 Billion |
| Forecasted Market Value (USD) by 2027 | $120.56 Billion |
| Compound Annual Growth Rate | 11.0% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Microbiome Market Trends
1.1 Microbiome Market Summary
1.2 Emerging Integrators
1.3 Major Probiotic Companies
1.4 Examples of Industrial Chains
1.5 Postbiotics
1.6 Regulation
1.7 Technology Platform Overview
1.8 Fecal Microbial Transplantation (FMT)
1.9 Encapsulation Technology
Chapter 2. Analysis by Microbiome application
2.1 Therapeutics
2.2 Diagnosis
2.3 Functional Food
2.4 Skin Care
2.5 Agriculture, Livestock and Fisheries
2.6 Industrial and other
Chapter 3. Trend Analysis by Company
3.1 Seres Therapeutics
3.2 Rebiotix
3.3 Evelo Biosciences
3.4 IFF(DuPont)
3.5 Chr. Hansen
3.6 Nestle
3.7 Probi
3.8 Yakult
3.9 Morinaga
Chapter 4. Market Size Forecast
Chapter 5. Trend Analysis by Country
Chapter 6. Conclusion
6.1. Competitive Environment Analysis
6.2 Digital Platforms and Marketing Strategies
6.3 Conclusion
Companies Mentioned
- BGI
- Chr. Hansen
- DuPont
- Enterome
- Evelo Biosciences
- Gallinee
- Illumina
- L’Oreal
- Morinaga
- Nestle
- Probi
- Rebiotix
- Seres Therapeutics
- Vedanta Biosciences
- Yakult Honsha
For more information about this report visit https://www.researchandmarkets.com/r/jucl1p
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
